A LALIGA footballer has been forced to step away from the game indefinitely because his cancer returned. It comes just two-and-a-half years after he was first diagnosed with Hodgkin’s lymphoma.
Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.
American Oncology Institute in Kanuru performs successful paediatric bone marrow transplant for Hodgkin’s Lymphoma patient, marking a milestone in cancer care.